The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
Seong Kyun NaGwang Hyeon ChoiHan Chu LeeYong Moon ShinJihyun AnDanbi LeeJu Hyun ShimKang Mo KimYoung-Suk LimYoung-Hwa ChungYung Sang LeePublished in: PloS one (2018)
The GE cHCC-CC group showed better response and prognosis after TACE than the PE cHCC-CC group, but poorer response and prognosis than the HCC-control group. Enhancement patterns at recurrence were crucially associated with tumor response and overall survival.